The Journal of clinical psychiatry · 2006
The nature of the discontinuation syndrome associated with antidepressant drugs.
СтатьяПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shelton Richard C
Аннотация
A common phenomenon accompanying treatment with nearly every major class of antidepressant is the emergence of the discontinuation syndrome in some patients. It is seen most frequently after the abrupt cessation of agents with shorter half-lives. The term withdrawal has been used in the past; however, the distinctions between discontinuation symptoms and drug withdrawal are clear. Thus, the use of proper terminology when discussing this phenomenon with patients will help to alleviate concerns and stop the spread of common misperceptions. In addition, awareness of the unique nature of discontinuation effects and a grasp of the typical time frame of their emergence can assist in distinguishing between discontinuation syndrome and relapse. As a result, it is vital that both patients and their relatives, especially caregivers, be provided with adequate education and a realistic and objective appraisal of expected outcomes upon initiation of antidepressant treatment.
Предметные рубрики MeSH
Antidepressive AgentsBehavior, AddictiveCaregiversDepressive DisorderDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansInfant, NewbornMaternal-Fetal ExchangeNeonatal Abstinence SyndromePatient Education as TopicPregnancySelective Serotonin Reuptake InhibitorsSubstance Withdrawal SyndromeSyndromeTerminology as Topic